Epstein-Barr virus in the pathogenesis of Hodgkin's disease

Biomedicine and Pharmacotherapy

Volumn 52, Issue 1, 1998, Pages 13-25

  Dolcetti, R ^a   Boiocchi, M ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Epstein Barr virus; Hodgkin's disease; Lymphomagenesis

Indexed keywords

ANTIGEN EXPRESSION; EPSTEIN BARR VIRUS; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEROEPIDEMIOLOGY; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS EXPRESSION; VIRUS IMMUNITY; VIRUS INFECTION;

EID: 0031908038     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(97)86237-3     Document Type: Article

References (170)

1. 1 Haluska FG, Brufsky AM, Canellos GP. The cellular biology of the Reed-Sternberg cell. Blood 1994 ; 34 : 1005-19
2. 2 Isaacson PG, Schmid C, Pan L, Wotherspoon AC, Wright DH, Epstein-Barr virus latent membrane protein expression by Hodgkin and Reed-Sternberg-like cells in acute infectious mononucleosis. J Pathol 1992 ; 167 : 267-71
3. 3 Strum SB, Rappaport H. Interrelations of the histologic-types of Hodgkin's disease. Arch Pathol 1971 ; 91 : 127-39
4. 4 Tsang WY, Chan JK, Ng CS. The nature of Reed-Sternberg-like cells in chronic lymphocytic leukemia. Am J Clin Pathol 1993 ; 99 : 317-23
5. 5 Weiss LM, Movahed LA, Warnke RA, Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 1989 ; 320 : 502-6
6. 6 Chu WS, Abbondanzo SL, Frizzera G. Inconsistency of the immunophenotype of Reed-Sternberg cells in simultaneous and consecutive specimens from the same parents. A paraffin section evaluation in 56 patients. Am J Patliol 1992 ; 141 : 11-17
7. 7 Drexler HG. Recent results on the biology of Hodgkin and Reed-Sternberg cells. I. Biopsy material. Leuk Lymphoma 1992 ; 8 : 283-313
8. 8 Hummel M, Marafioti T, Ziemann K, Stein H. Ig rearrangements in isolated Reed-Sternberg cells : conclusions from four different studies. Ann Oncol 1996 ; 7 : S31-3
9. 9 Anastasi J, Variakojis D. Heterogeneity in Hodgkin's disease : no simple answer for a complex disorder. Hum Pathol 1988 ; 19 : 3251-4
10. 10 Butler JJ. Relationship of histologic findings to survival in Hodgkin's disease. Cancer Res 1971 ; 31 : 1770-5
11. 11 Colby TV, Hoppe RT, Warnke RA. Hodgkin's disease : a clinicopathologic study of 659 cases. Cancer 1981 ; 49 : 1848-58
12. 12 MacLennan KA, Bennett MH, Tu A, Hudson BV, Easterling MJ, Hudson GV, Jelliffe AM. Relationship of histopathologic features to survival and relapse in nodular sclerosing Hodgkin's disease. A study of 1659 patients. Cancer 1989 ; 64 : 1686-93
13. 13 Henle G, Henle W. Observations on childhood infections with the Epstein-Barr virus. J Infect Dis 1970 ; 121 : 303-10
14. 14 Niederman JC, Evans AS, Subrahmanyan L, McCollum RW. Prevalence, incidence and persistence of EB virus antibody in young adults. New Engl J Med 1970 ; 282 : 361-5
15. 15 Henle G, Henle W, Diehl V. Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis. Proc Natl Acad Sci USA 1968 ; 59 : 94-101
16. 16 Nilsson K, Klein G, Henle W, Henle G. The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV. Int J Cancer 1971 ; 8 : 443-50
17. 17 Greenspan JS, Greenspan D, Lennette ET, Abrams DI. Conant MA, Petersen V, Freese UK. Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukopiakia, an AIDS-associated lesion. N Engl J Med 1985 ; 313 : 1564-71
18. 18 Raab Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986 ; 47 : 883-9
19. 19 Hurley EA, Thorley Lawson DA. B cell activation and the establishment of Epstein-Barr virus latency. J Exp Med 1988 ; 168 : 2059-75
20. 20 Cleary ML, Nalesnik MA, Shearer WT, Sklar J. Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood 1988 ; 72 : 349-52
21. 21 Kieff E, Liebowitz D. Epstein-Barr virus and its replication. In : Fields BN, Knipe DM, eds. Virology. New York : Raven Press ; 1990. p 1889
22. 22 Rogers RP, Strominger JL, Speck SH. Epstein-Barr virus in B lymphocytes : viral gene expression and function in latency. Adv Cancer Res 1992 ; 58 : 1-26
23. 23 Jat P, Arrand JR. In vitro transcription of two Epstein-Barr virus specified small RNA molecules. Nucleic Acids Res 1982 ; 10 : 3407-25
24. 24 Lerner MR, Andrews NC, Miller G, Steitz JA. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 1981 ; 78 : 805-9
25. 25 Kerr BM, Lear AL, Rowe M, Croom Carter D, Young LS, Rookes SM et al. Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids : cell phenotype dependence of virus promoter usage. Virology 1992 ; 187 : 189-201
26. 26 Rowe M, Lear AL, Croom Carter D, Davies AH, Rickinson AB. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes J Virol 1992 ; 66 : 122-31
27. 27 Rowe M, Rowe DT, Gregory CD, Young LS, Farrell PJ, Rupani H, Rickinson AB. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J 1987 ; 6 : 2743-51
28. 28 Gilligan KJ, Rajadurai P, Lin JC, Busson P, Abdel Hamid M, Prasad U et al. Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma : evidence for a viral protein expressed in vivo. J Virol 1991 ; 65 : 6252-9
29. 29 Young LS, Dawson CW, Clark D, Rupani H, Busson P, Tursz T et al. Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 1988 ; 69 : 1051-65
30. 30 Chen CL, Sadler RH, Walling DM, Su IJ, Hsieh HC, Raab Traub N. Epstein-Barr virus [EBV] gene expression in EBV-positive peripheral T-cell lymphomas. J Virol 1993 ; 67 : 6303-8
31. 31 Tierney RJ, Steven N, Young LS, Rickinson AB. Epstein-Barr virus latency in blood mononuclear cells : analysis of viral gene transcription during primary infection and in the carrier state. J Virol 1994 ; 68 : 7374-85
32. 32 Chen F, Zou JZ, di Renzo L, Winberg G, Hu LF, Klein E et al. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J Virol 1995 ; 69 : 3752-8
33. 33 Qu L, Rowe DT. Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes. J Virol 1992 ; 66 : 3715-24
34. 34 Middleton T, Gahn TA, Martin JM, Sugden B. Immortalizing genes of Epstein-Barr virus. Adv Virus Res 1991 ; 40 : 19-55
35. 35 Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Sculley TB et al. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia : implications for vaccine development. J Exp Med 1992 ; 176 : 169-76
36. 36 Murray RJ, Kurilla MG, Brooks JM, Thomas WA, Rowe M, Kieff E, Rickinson AB. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus [EBV] : implications for the immune control of EBV-positive malignancies. J Exp Med 1992 ; 176 : 157-68
37. 37 Shapiro RS, McClain K, Frizzera G, Gajl Peczalska KJ, Kersey JH, Blazar BR, Arthur DC et al. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 1988 ; 71 : 1234-43
38. 38 Thomas JA, Allday MJ, Crawford DH. Epstein-Barr virus-associated lymphoproliferative disorders in immunocompromised individuals. Adv Cancer Res 1991 ; 57 : 329-80
39. 39 Zutter MM, Martin PJ, Sale GE, Shulman HM, Fisher L, Thomas ED, Durnam DM. Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 1988 ; 72 : 520-9
40. 40 Miller G. The switch between latency and replication of Epstein-Barr virus. J Infect Dis 1990 ; 161 : 833-44
41. 41 Adldinger HK, Delius H, Freese UK, Clarke J, Bornkamm GW. A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes. Virology 1985 ; 141 : 221-34
42. 42 Rowe M, Young LS, Cadwallader K, Petti L, Kieff E, Rickinson AB. Distinction between Epstein-Barr virus type A [EBNA 2A] and type B [EBNA 2B] isolates extends to the EBNA 3 family of nuclear proteins. J Virol 1989 ; 63 : 1031-9
43. 43 Sculley TB, Apolloni A, Stumm R, Moss DJ, Mueller Lantezh N, Misko IS, Cooper DA. Expression of Epstein-Barr virus nuclear antigens 3, 4, and 6 are altered in cell lines containing B-type virus. Virology 1989 ; 171 : 401-8
44. 44 Rickinson AB, Young LS, Rowe M. Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J Virol 1987 ; 61 : 1310-17
45. 45 Gratama JW, Ernberg I. Molecular epidemiology of Epstein-Barr virus infection. Adv Cancer Res 1995 ; 67 : 197-255
46. 46 Sixbey JW, Shirley P, Chesney PJ, Buntin DM, Resnick L. Detection of a second widespread strain of Epstein-Barr virus. Lancer 1989 ; II : 761-5
47. 47 Wolf J, Diehl V. Is Hodgkin's disease an infectious disease? Ann Oncol 1994 ; 5 Suppl 1 : S105-11
48. 48 orrea P, O'Conor GT. Epidemiologic patterns of Hodgkin' disease. Int J Cancer 1971 ; 8 : 192-201
49. 49 MacMahon B. Epidemiology of Hodgkin's disease. Cancer Res 1966 ; 26 : 1189-200
50. 50 Glaser SL, Swartz WG. Time trends in Hodgkin's disease incidence. The role of diagnostic accuracy. Cancer 1990 ; 66 : 2196-204
51. 51 McKinney PA, Alexander FE, Ricketts TJ, Williams J, Cartwright RA. A specialist leukaemia/lymphoma registry in the UK. Part I : Incidence and geographical distribution of Hodgkin's disease. Leukaemia Research Fund Data Collection Study Group. Br J Cancer 1989 ; 60 : 942-7
52. 52 Spitz MR, Sider JG, Johnson CC, Butler JJ, Pollack ES, Newell GR. Ethnic patterns of Hodgkin's disease incidence among children and adolescents in the United States, 197382. J Natl Cancer Inst 1986 ; 76 : 235-9
53. 53 Macfarlane GJ, Evstifeeva T, Boyle P, Grufferman S. International patterns in the occurrence of Hodgkin's disease in children and young adult males. Int J Cancer 1995 ; 61 : 165-9
54. 54 Gutensohn NM. Social class and age at diagnosis of Hodgkin's disease : new epidemiological evidence for the 'two-disease hypothesis'. Cancer Treat Rep 1982 ; 66 : 689-95
55. 55 Gutensohn NM, Cole P. Childhood social environment and Hodgkin's disease. N Engl J Med 1981 ; 304 : 135-40
56. 56 Vianna NJ, Greenwald P, Davies JNP. Extended epidemic of Hodgkin's disease in high-school students. Lancet 1971 ; I : 1209-10
57. 57 Alexander FE. Clustering and Hodgkin's disease. Br J Cancer 1990 ; 62 : 708-11
58. 58 Kvale G, Hoiby EA, Pedersen E. Hodgkin's disease in patients with previous infectious mononucleosis. Cancer 1979 ; 23 : 593-7
59. 59 Munoz N, Davidson RJ, Witthoff B, Ericsson JE, De-The G. Infectious mononucleosis and Hodgkin's disease. Int J Cancer 1978 ; 22 : 10-13
60. 60 Rosdahl N, Larsen SO, Clemmesen J. Hodgkin's disease in patients with previous infectious mononucleosis : 30 years'experience. Br Med J 1974 ; 2 : 253-6
61. 61 Johansson B, Klein G, Henle W, Henle G. Epstein-Barr virus [EBV]-associated antibody patterns in malignant lymphoma and leukemia. I. Hodgkin's disease. Int J Cancer 1970 ; 6 : 450-62
62. 62 Levine PH, Ablashi DV, Bernard CV, Carbone PP, Waggoner DE, Malan L. Elevated antibody titers to Epstein-Barr virus in Hodgkin's disease. Cancer 1971 ; 27 : 416-21
63. 63 Mueller N, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K et al. Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N Engl J Med 1989 ; 320 : 689-95
64. 64 Anagnostopoulos I, Herbst H, Niedobitek G, Stein H. Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood 1989 ; 74 : 810-16
65. 65 Boiocchi M, Carbone A, De Re V, Dolcetti R. Is the Epstein-Barr virus involved in Hodgkin's disease? Tumori 1989 ; 75 : 345-50
66. 66 Staal SP, Ambinder R, Beschorner WE, Hayward GS, Mann R. A survey of Epstein-Barr virus DNA in lymphoid tissue. Frequent detection in Hodgkin's disease. Am J Clin Pathol 1989 ; 91 : 1-5
67. 67 Weiss LM, Strickler JG, Warnke RA, Purtilo DT, Sklar J. Epstein-Barr viral DNA in tissues of Hodgkin's disease. Am J Pathol 1987 ; 129 : 86-91
68. 68 Boiocchi M, De Re V, Gloghini A, Vaccher E, Dolcetti R, Marzotto A et al. High incidence of monoclonal EBV episomes in Hodgkin's disease and anaplastic large-cell KI-1-positive lymphomas in HIV-1-positive patients. Int J Cancer 1993 ; 54 : 53-9
69. 69 Brousset P, Chittal S, Schlaifer D, Icart J, Payen C, Rigal Huguet F et al. Detection of Epstein-Barr virus messenger RNA in Reed-Sternberg cells of Hodgkin's disease by in situ hybridization with biotinylated probes on specially processed modified acetone methyl benzoate xylene [ModAMeX] sections. Blood 1991 ; 77 : 1781-6
70. 70 Uhara H, Sato Y, Mukai K, Akao I, Matsuno Y, Furuya S et al. Detection of Epstein-Barr virus DNA in Reed-Sternberg cells of Hodgkin's disease using the polymerase chain reaction and in situ hybridization. Jpn J Cancer Res 1990 ; 81 : 272-8
71. 71 Howe JG, Steitz JA. Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization. Proc Natl Acad Sci USA 1986 ; 83 : 9006-10
72. 72 Weiss LM, Chen YY, Liu XF, Shibata D. Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study. Am J Pathol 1991 ; 139 : 1259-65
73. 73 Wu TC, Mann RB, Charache P, Hayward SD, Staal S, Lambe BC, Ambinder RF. Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease. Int J Cancer 1990 ; 46 : 801-4
74. 74 Ambinder RF, Browning PJ, Lorenzana I, Leventhal BG, Cosenza H, Mann RB et al. Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. Blood 1993 ; 81 : 462-7
75. 75 Gulley ML, Eagan PA, Quintanilla Martinez L, Picado AL, Smir BN, Childs C et al. Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin's disease : association with mixed cellularity subtype and Hispanic American ethnicity. Blood 1994 ; 83 : 1595-602
76. 76 Zhou XG, Hamilton Dutoit SJ, Yan QH, Pallesen G. The association between Epstein-Barr virus and Chinese Hodgkin's disease. Int J Cancer 1993 ; 55 : 359-63
77. 77 Armstrong AA, Weiss LM, Gallagher A, Jones DB, Krajewski AS, Angus B et al. Criteria for the definition of Epstein-Barr virus association in Hodgkin's disease. Leukemia 1992 ; 6 : 869-74
78. 78 Masih A, Weisenburger D, Duggan M, Armitage J, Bashir R, Mitchell D et al. Epstein-Barr viral genome in lymph nodes from patients with Hodgkin's disease may not be specific to Reed-Sternberg cells. Am J Pathol 1991 ; 139 : 37-43
79. 79 Valente G, Negro F, Pacchioni D, Palestro G. Infection by Epstein-Barr virus in Hodgkin's disease is not restricted to the Reed-Sternberg cells. Br J Haematol 1994 ; 86 : 405-6
80. 80 Roth J, Daus H, Gause A, Trumper L, Pfreundschuh M. Detection of Epstein-Barr virus DNA in Hodgkin- and Reed-Sternberg-cells by single cell PCR. Leuk Lymphoma 1994 ; 13 : 137-42
81. 81 Boyle MJ, Vasak E, Tschuchnigg M, Turner JJ, Sculley T, Penny R et al. Subtypes of Epstein-Barr virus [EBV] in Hodgkin's disease : association between B-type EBV and immunocompromise. Blood 1993 ; 81 : 468-74
82. 82 De Re V, Boiocchi M, De Vita S, Dolcetti R, Gloghini A, Uccini S et al. Subtypes of Epstein-Barr virus in HIV-1-associated and HIV-1-unrelated Hodgkin's disease cases. Int J Cancer 1993 ; 54 : 895-8
83. 83 Gledhill S, Gallagher A, Jones DB, Krajewski AS, Alexander FE, Klee E et al. Viral involvement in Hodgkin's disease : detection of clonal type A Epstein-Barr virus genomes in tumour samples. Br J Cancer 1991 ; 64 : 227-32
84. 84 Lin JC, Lin SC, De BK, Chan WP, Evatt BL. Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3C, and EBER) : predominance of type A virus associated with Hodgkin's disease. Blood 1993 ; 81 : 3372-81
85. 85 Boyle MJ, Sewell WA, Sculley TB, Apolloni A, Turner JJ, Swanson CE et al. Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphoma. Blood 1991 ; 78 : 3004-11
86. 86 Boiocchi M, De Re V, Dolcetti R, Carbone A, Scarpa A, Menestrina F. Association of Epstein-Barr virus genome with mixed cellularity and cellular phase nodular sclerosis Hodgkin's disease subtypes. Ann Oncol 1992 ; 3 : 307-10
87. 87 Jarrett AF, Armstrong AA, Alexander E. Epidemiology of EBV and Hodgkin's lymphoma. Ann Oncol 1996 ; 7 : S5-10
88. 88 Carbone A, Tirelli U, Vaccher E, Volpe R, Gloghini A, Bertola G et al. A clinicopathologic study of lymphoid neoplasias associated with human immunodeficiency virus infection in Italy. Cancer 1991 ; 68 : 842-52
89. 89 Tirelli U, Errante D, Dolcetti R, Gloghini A, Serraino D, Vaccher E et al. Hodgkin's disease and human immunodeficiency virus infection : clinicopathologic and virologie features of 114 patients from the Italian Cooperative Group on AIDS and Tumors. J Clin Oncol 1995 ; 13 : 1758-67
90. 90 Uccini S, Monardo F, Ruco LP, Baroni CD, Faggioni A, Agliano AM et al. High frequency of Epstein-Barr virus genome in HIV-positive patients with Hodgkin's disease. Lancet 1989 ; 1 : 1458
91. 91 Armstrong AA, Alexander FE, Paes RP, Morad NA, Gallagher A, Krajewski AS et al. Association of Epstein-Barr virus with pediatric Hodgkin's disease. Am J Pathol 1993 ; 142 : 1683-8
92. 92 O'Grady J, Stewart S, Elton RA, Krajewski AS. Epstein-Barr virus in Hodgkin's disease and site of origin of tumour. Lancet 1994 ; 343 : 265-6
93. 93 Sixbey JW, Nedrud JG, Raab Traub N, Hanes RA, Pagano JS. Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 1984 ; 310 : 1225-30
94. 94 Boiocchi M, Dolcetti R, De Re V, Gloghini A, Carbone A. Demonstration of a unique Epstein-Barr virus-positive cellular clone in metachronous multiple localizations of Hodgkin's disease. Am J Pathol 1993 ; 142 : 33-8
95. 95 Coates PJ, Slavin G, D'Ardenne AJ. Persistence of Epstein-Barr virus in Reed-Sternberg cells throughout the course of Hodgkin's disease. J Pathol 1991 ; 164 : 291-7
96. 96 Vasef MA, Kamel OW, Chen YY, Medeiros LJ, Weiss LM. Detection of Epstein-Barr virus in multiple sites involved by Hodgkin's disease. Am J Pathol 1995 ; 147 : 1408-15
97. 97 Brousset P, Schlaifer D, Meggetto F, Bachmann E, Rothenberger S, Pris J et al. Persistence of the same viral strain in early and late relapses of Epstein-Barr virus-associated Hodgkin's disease. Blood 1994 ; 84 : 2447-51
98. 98 Grasser FA, Murray PG, Kremmer E, Klein K, Remberger K, Feiden W et al. Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 [EBNA1] : immimohistologic detection of EBNA1 in the malignant cells of Hodgkin's disease. Blood 1994 ; 84 : 3792-8
99. 99 Herbst H, Dallenbach F, Hummel M, Niedobitek G, Pileri S, Muller Lantzsch N, Stein H. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci USA 1991 ; 88 : 4766-70
100. 100 Pallesen G, Hamilton Dutoit SJ, Rowe M, Young LS. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 1991 ; 337 : 320-2
101. 101 Deacon EM, Pallesen G, Niedobitek G, Crocker J, Brooks L, Rickinson AB, Young LS. Epstein-Barr virus and Hodgkin's disease : transcriptional analysis of virus latency in the malignant cells. J Exp Med 1993 ; 177 : 339-49
102. 102 Pallesen G, Sandvej K, Hamilton Dutoit SJ, Rowe M, Young LS. Activation of Epstein-Barr virus replication in Hodgkin and Reed-Sternberg cells. Blood 1991 ; 78 : 1162-5
103. 103 Brousset P, Knecht H, Rubin B, Drouet E, Chittal S, Meggetto F et al. Demonstration of Epstein-Barr virus replication in Reed-Sternberg cells of Hodgkin's disease. Blood 1993 ; 82 : 872-6
104. 104 Bai MC, Jiwa NM, Horstman A, Vos W, Kluin PH, Van der Valk P et al. Decreased expression of cellular markers in Epstein-Barr virus-positive Hodgkin's disease. J Pathol 1994 ; 174 : 49-55
105. 105 Herbst H, Raff T, Stein H. Phenotypic modulation of Hodgkin and Reed-Sternberg cells by Epstein-Barr virus. J Pathol 1996 ; 179 : 54-9
106. 106 Niedobitek G, Herbst H, Young LS, Brooks L, Masucci MG, Crocker J, Rickinson AB, Stein H. Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. Bood 1992 ; 79 : 2520-6
107. 107 Wilson JB, Levine AJ. The oncogenic potential of Epstein-Barr virus nuclear antigen 1 in transgenic mice. Curr Top Microbiol Immunol 1992 ; 182 : 375-84
108. 108 Dawson CW, Rickinson AB, Young LS. Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 1990 ; 344 : 777-80
109. 109 Fahracus R, Rymo L, Rhim JS, Klein G. Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature 1990 ; 345 : 447-9
110. 110 Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985 ; 43 : 831-40
111. 111 Kaye KM, Izumi KM, Kieff E. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA 1993 ; 90 : 9150-4
112. 112 Calender A, Billaud M, Aubry J, Banchereau J, Vuillaume M, Lenoir G. EBV induces expression of B cell activation markers on in vitro infection of EBV negative B lymphoma cells. Proc Natl Acad Sci USA 1987 ; 84 : 8060-4
113. 113 Wang D, Liebowitz D, Wang F, Gregory C, Rickinson A, Larson R et al. Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype : deletion of the amino terminus abolishes activity. J Virol 1988 ; 62 : 4173-84
114. 114 Henderson S, Rowe M, Gregory C, Croom Carter D, Wang F, Longnecker R et al. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991 ; 65 : 1107-15
115. 115 Armstrong AA, Gallagher A, Krajewski AS, Jones DB, Wilkins BS, Onions DE, Jarrett RF. The expression of the EBV latent membrane protein [LMP-1] is independent of CD23 and bcl-2 in Reed-Sternberg cells in Hodgkin's disease. Histopathology 1992 ; 21 : 72-3
116. 116 Jiwa NM, Kanavaros P, Van der Valk P, Walboomers JM, Horstman A, Vos W et al. Expression of c-myc and bcl-2 oncogene producls in Reed-Sternberg cells independent of presence of Epstein-Barr virus. J Clin Pathol 1993 ; 46 : 211-17
117. 117 Khan G, Gupta RK, Coates PJ, Slavin G. Epstein-Barr virus infection and bcl-2 proto-oncogene expression. Separate events in the pathogenesis of Hodgkin's disease? Am J Pathol 1993 ; 143 : 1270-4
118. 118 O'Grady JT, Stewart S, Lowrey J, Howie SE, Krajewski AS. CD40 expression in Hodgkin's disease. Am J Pathol 1994 ; 144 : 21-6
119. 119 Momose H, Jaffe ES, Shin SS, Chen YY, Weiss LM. Chronic lymphocytic leukemia/small lymphocytic lymphoma with Reed-Sternberg-like cells and possible transformation to Hodgkin's disease. Mediation by Epstein-Barr virus. Am J Surg Pathol 1992 ; 16 : 859-67
120. 120 Birkenbach M, Liebowitz D, Wang F, Sample J, Kieff E. Epstein-Barr virus latent infection membrane protein increases vimentin expression in human B-cell lines. J Virol 1989 ; 63 : 4079-84
121. 121 Liebowitz D, Kopan R, Fuchs E, Sample J, Kieff E. An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes. Mol Cell Biol 1987 ; 7 : 2299-308
122. 122 Hudson GS, Farrell PJ, Barrell BG. Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein-Barr virus B95-8. J Virol 1985 ; 53 : 528-35
123. 123 Moorthy RK, Thorley Lawson DA. All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts. J Virol 1993 ; 67 : 1638-46
124. 124 Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 1995 ; 80 : 389-99
125. 125 Huen DS, Henderson SA, Croom Carter D, Rowe M. The Epstein-Barr virus latent membrane protein-1 [LMP1] mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 1995 ; 10 : 549-60
126. 126 Mori N, Shirakawa F, Shimizu H, Murakami S, Oda S, Yamamoto K, Eto S. Transcriptional regulation of the human interleukin-6 gene promoter in human T-cell leukemia virus type I-infected T-cell lines : evidence for the involvement of NF-kappa B. Blood 1994 ; 84 : 2904-11
127. 127 Kim JM, Brannan CI, Copeland NG, Jenkins NA, Khan TA, Moore KW. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J Immunol 1992 ; 148 : 3618-23
128. 128 Burdin N, Peronne C, Banchereau J, Rousset F. Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10. J Exp Med 1993 ; 177 : 295-304
129. 129 Tosato G, Tanner J, Jones KD, Revel M, Pike SE. Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells. J Virol 1990 64 : 3033-41
130. 130 Nakagomi H, Dolcetti R, Bejarano MT, Pisa P, Kiessling R, Masucci MG. The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines. Int J Cancer 1994 ; 57 : 240-44
131. 131 Rochford R, Dawson CW, Mosier DE, Young LS. Epstein-Barr virus latent proteins activated cytokine gene expression in epithelial cells. In : Pagano JS, Rickinson AB, eds. Cold Spring Harbor Meeting on cancer cells. Cold Spring Harbor : Cold Spring Harbor Laboratory ; 1994
132. 132 Herbst H, Foss HD, Samol J, Araujo I, Klotzbach H, Krause H et al. Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease. Blood 1996 ; 87 : 2918-29
133. 133 Herbst H. Epstein-Barr virus in Hodgkin's disease. Cancer Biol 1996 ; 7 : 183-9
134. 134 Cuomo L, Trivedi P, Wang F, Winberg G, Klein G, Masucci MG. Expression of the Epstein-Barr virus [EBV]-encoded membrane antigen [LMP] increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures. Eur J Immunol 1990 ; 20 : 2293-9
135. 135 Peng M, Lundgren E. Transient expression of the Epstein-Barr virus LMP1 gene in B-cell chronic lymphocytic leukemia cells, T cells, and hematopoietic cell lines : cell-type-independent-induction of CD23, CD21, and ICAM-1. Leukemia 1993 ; 7 : 104-12
136. 136 Knecht H, Bachmann E, Brousset P, Sandvej K, Nadal D, Bachmann F et al. Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 1993 ; 82 : 2937-42
137. 137 Sandvej K, Peh SC, Andresen BS, Pallesen G. Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus [EBV] BNLF-1 gene in both malignant and benign EBV-associated diseases : high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood 1994 ; 84 : 4053-60
138. 138 Santon A, Manzanal A, Campo E, Bellas C. Deletions in the Epstein-Barr virus latent membrane protein-1 oncogene in Hodgkin's disease. J Clin Pathol Mol Pathol 1995 ; 48 : M184-7
139. 139 Knecht H, Bachmann E, Brousset P, Rothenberger S, Einsele H, Lestou VS et al. Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders. Oncogene 1995 ; 10 : 523-28
140. 140 Knecht H, Martius F, Bachmann E, Hoffman T, Zimmermann DR, Rothenberger S et al. A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma. Leukemia 1995 ; 9 : 458-65
141. 141 Chen ML, Tsai CN, Liang CL, Shu CH, Huang CR, Sulitzeanu D et al. Cloning and characterization of the latent membrane protein [LMP] of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 1992 ; 7 : 2131-40
142. 142 Hu LF, Zabarovsky ER, Chen F, Cao SL, Ernberg I, Klein G, Winberg G. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene [LMP1] from a Chinese nasopharyngeal carcinoma. J Gen Virol 1991 ; 72 : 2399-409
143. 143 Hu LF, Chen F, Zheng X, Ernberg I, Cao SL, Christensson B et al. Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. Oncogene 1993 ; 8 : 1575-83
144. 144 Li SN, Chang YS, Liu ST. Effect of a 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus. Oncogene 1996 ; 12 : 2129-35
145. 145 Trivedi P, Hu LF, Chen F, Christensson B, Masucci MG, Klein G, Winberg G. Epstein-Barr virus [EBV]-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologue. Eur J Cancer 1994 ; 30A : 84-8
146. 146 De Campos Lima PO, Gavioli R, Zhang QJ, Wallace LE, Dolcetti R, Rowe M et al. HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population. Science 1993 ; 260 : 98-100
147. 147 Dolcetti R, Zancai P, De Re V, Gloghini A, Bigoni B, Pivetta B et al. Epstein-Barr virus strains with latent membrane protein-1 deletions : prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin's disease. Blood 1997 ; 89 : 1723-31
148. 148 Slivnick DJ, Ellis TM, Nawrocki JF, Fisher RI. The impact of Hodgkin's disease on the immune system. Semin Oncol 1990 ; 17 : 673-82
149. 149 Chen HF, Kevan Jah S, Suentzenich KO, Grasser FA, Mueller Lantzsch N. Expression of the Epstein-Barr virus latent membrane protein [LMP] in insect cells and detection of antibodies in human sera against this protein. Virology 1992 ; 190 : 106-15
150. 150 Frisan T, Sjoberg J, Dolcetti R, Boiocchi M, De Re V, Carbone A et al. Local suppression of Epstein-Barr virus [EBV]-specific cytotoxicily in biopsies of EBV-positive Hodgkin's disease. Blood 1995 ; 86 : 1493-501
151. 151 Dolcetti R, Frisan T, Sjoberg J, De Campos Lima PO, Pisa P, De Re V et al. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease. Cancer Res 1995 ; 55 : 3675-81
152. 152 Oudejans JJ, Jiwa NM, Kummer JA, Horstman A, Vos W, Baak JP, Kluin PM et al. Analysis of major histocompatibility complex class I expression on Reed-Sternberg cells in relation to the cytotoxic T-cell response in Epstein-Barr virus-positive and -negative Hodgkin's disease. Blood 1996 ; 87 : 3844-51
153. 153 de Waal Malcfyt R, Yssel H, Roncarolo MG, Spits H, de Vries JE. Interleukin-10. Curr Opin Immunol 1992 ; 4 : 314-20
154. 154 Boiocchi M, Dolcetti R, Carbone A. Pathogenesis of human reactive-appearing "non-monomorphous" malignant lymphoproliferative disorders : a hypothesis. Tumori 1992 ; 78 : 221-7
155. 155 Abruzzo LV, Schmidt K, Weiss LM, Jaffe ES, Medeiros LJ, Sander CA, Raffeld M. B-cell lymphoma after angioimmunoblastic lymphadenopathy : a case with oligoclonal gene rearrangements associated with Epstein-Barr virus. Blood 1993 ; 82 : 241-6
156. 156 Dolcetti R, Carbone A, Zagonel V, De Re V, Gloghini A, Frisan T, Boiocchi M. Type 2 Epstein-Barr virus genome and latent membrane protein-1 expression in a T-cell-rich lymphoma of probable B-cell lineage. Am J Clin Pathol 1993 ; 100 : 541-9
157. 157 Loke SL, Ho F, Srivastava G, Fu KH, Leung B, Liang R. Clonal Epstein-Barr virus genome in T-cell-rich lymphomas of B or probable B lineage. Am J Pathol 1992 ; 140 : 981-9
158. 158 Weiss LM, Jaffe ES, Liu XF, Chen YY, Shibata D, Medeiros LJ. Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood 1992 ; 79 : 1789-95
159. 159 Zimber-Strobl U, Kempkes B, Marschall G, Zeidler R, Van Kooten C, Banchereau J et al. Epstein-Barr virus latent membrane protein [LMP1] is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival. EMBO J 1996 ; 15 : 7070-8
160. 160 DeKruyff RH, Brown PH, Thorbecke GJ, Ponzio NM. Characterization of SJL T cell clones responsive to syngeneic lymphoma [RCS] : RCS-specific clones are stimulated by activated B cells. J Immunol 1985 ; 135 : 3581-6
161. 161 Haran-Ghera N, Katler M, Meshores A. Studies on leukemia development in the SJL/J strain of mice. J Natl Cancer Inst 1967 ; 39 : 653-61
162. 162 Katz IR, Chapman-Alexander J, Jacobson EB, Lerman SP, Thorbecke GJ. Growth of SJL/J-derived transplantable reticulum cell sarcoma as related to its ability to induce T-cell proliferation in the host. III. Studies on thymectomized and congenitally athymic SJL mice. Cell Immunol 1981 ; 65 : 84-92
163. 163 Katz JD, Lebow LT, Bonavida B. The in vivo depletion of V beta 17a+ T cells results in the inhibition of reticulum cell sarcoma growth in SJL/J mice. Evidence for the use of anticlonotypic antibody therapy in the control of malignancy. J Immunol 1989 ; 143 : 1387-95
164. 164 Lasky JL, Ponzio NM, Thorbecke GJ. Characterization and growth factor requirements of SJL lymphomas. I. Development of a B cell growth factor-dependent in vitro cell line, cRCS-X. J Immunol 1988 ; 140 : 679-87
165. 165 Lasky JL, Thorbecke GJ. Characterization and growth factor requirements of SJL lymphomas. II. Interleukin 5 dependence of the in vitro cell line, cRCS-X, and influence of other cytokines. Eur J Immunol 1989 ; 19 : 365-71
166. 166 Nakauchi H, Osada H, Yagita H, Okumura K. Molecular evidence that SJL reticulum cell sarcomas are derived from pre-B cell. Clonal rearrangement of heavy chain but not of light chain iminunoglobulin genes. J Immunol 1987 ; 139 : 2803-9
167. 167 Ponzio NM, Lerman SP, Chapman JM, Thorbecke GJ. Properties of reticulum cell sarcomas in SJL/J mice. IV. Minimal development of cytotoxic cells despite marked proliferation to syngeneic RCS in vivo and in vitro. Cell Immunol 1977 ; 32 : 10-22
168. 168 Siegler R, Rich MA. Pathogenesis of reticulum cell sarcoma in mice. J Natl Cancer Inst 1968 ; 41 : 125-43
169. 169 Veronese ML, Veronesi A, D'Andrea E, Del Mistro A. Indraccolo S, Mazza MR, Mion M et al. Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. I. T lymphocyte requirement for B cell tumor generation. J Exp Med 1992 ; 176 : 1763-7
170. 170 Herbst H, Steinbrecher E, Niedobitek G, Young LS, Brooks L, Muller Lantzsch N, Stein H. Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease. Blood 1992 ; 80 : 484-91